| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 106 |
| 1 | RITUXIMAB | 77 |
| 2 | ETANERCEPT | 76 |
| 3 | ABATACEPT | 75 |
| 4 | TOCILIZUMAB | 75 |
| 5 | INFLIXIMAB | 74 |
| 6 | LEFLUNOMIDE | 73 |
| 7 | SULFASALAZINE | 73 |
| 8 | METHOTREXATE SODIUM | 70 |
| 9 | TOFACITINIB | 70 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CANNABIS SATIVA | 15 | 0.0181 |
| 1 | GOLD | 48 | 0.0113 |
| 2 | CANAKINUMAB | 48 | 0.0053 |
| 3 | ANAKINRA | 49 | 0.0038 |
| 4 | MINOCYCLINE HYDROCHLORIDE | 47 | 0.0036 |
| 5 | ACETYLSALICYCLIC ACID | 1 | 0.0034 |
| 6 | DOXYCLYCLINE HYCLATE | 18 | 0.0016 |
| 7 | SULFASALAZINE | 73 | 0.0011 |
| 8 | TECLISTAMAB | 1 | 0.0011 |
| 9 | DAUNORUBICIN HYDROCHLORIDE | 1 | 0.0009 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 49 | 0.0038 |
| 1 | Antirheumatic Agent [EPC] | 73 | 0.0008 |
| 2 | Standardized Chemical Allergen [EPC] | 49 | 0.0008 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 75 | 0.0007 |
| 4 | Aminosalicylate [EPC] | 73 | 0.0007 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 75 | 0.0007 |
| 6 | Tetracycline-class Drug [EPC] | 25 | 0.0005 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 78 | 0.0003 |
| 8 | Anticholinergic [EPC] | 4 | 0.0003 |
| 9 | GLP-2 Analog [EPC] | 2 | 0.0002 |